The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.525
Bid: 2.50
Ask: 2.55
Change: -0.015 (-0.59%)
Spread: 0.05 (2.00%)
Open: 2.575
High: 2.575
Low: 2.525
Prev. Close: 2.54
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

11 Jul 2022 07:00

RNS Number : 7675R
Brave Bison Group PLC
11 July 2022
 

11 July 2022

 

 

 

Brave Bison Group plc

 

("Brave Bison" or the "Company")

 

Appointment of Independent Non-Executive Director

 

Brave Bison, the social and digital media company, is pleased to announce that Gordon Brough will join the Board as an Independent Non-Executive Director with immediate effect.

 

Gordon was, until recently, General Counsel at CQS, the specialist asset manager with over $20bn of assets under management. Prior to CQS, Gordon was General Counsel at Aberdeen Asset Management plc (later Aberdeen Standard Investments, now the asset management arm of Abrdn) for almost 10 years. Mr Brough holds an LLB (Hons) and a Diploma in Legal Practice from the University of Dundee.

 

Gordon brings to the Board a wealth of experience in both the corporate and M&A spheres, as well governance, legal and compliance.

 

In addition to being appointed as an Independent Non-Executive Director of the Company, Gordon will chair the Audit and ESG Committees and will join the Remuneration Committee.

 

Gordon Brough holds 587,371 Ordinary Shares in the Company, representing 0.05 per cent. of the Company's issued ordinary share capital.

 

Oliver Green, Chairman, said:

"This appointment underscores the Board's commitment to ensuring growth is achieved in a thoughtful and measured way and in line with modern standards of governance. Gordon's extensive experience will bring great value to the business and I look forward to working with him."

 

In addition to his appointment to Brave Bison, Gordon Haig Brough, aged 62, is currently or has previously been a director or partner of the following companies or partnerships within the past five years:

Current

Former

PFD Agency Holdings Limited

CQS (UK) LLP

The Golden Charter Trust Limited

EPI 1 S.à r.l

EPI II S.a.r.l

Harverdale Limited

Georges Simenon Limited

Worldwrites Holdings Limited

 

For further information please contact:

 

Brave Bison Group plc

Oliver Green, Executive Chairman via Cenkos

Theo Green, Chief Growth Officer

Philippa Norridge, Chief Financial Officer

 

Cenkos Securities plc Tel: +44 (0)20 7397 8900

Nominated Adviser & Broker

Nicholas Wells

Ben Jeynes

 

About Brave Bison

 

Brave Bison (AIM: BBSN) is a social and digital media company, headquartered in London with a globally distributed workforce across eight countries.

 

Brave Bison is unique in that it is both a digital media owner, as well as a digital media agency. The Company owns and operates its own channels, and the communities attached to them, as well as offering customers a suite of advertising services to help reach digital audiences.

 

Brave Bison has two core lines of business. Firstly, the publishing of content on social media channels to generate advertising revenue. Brave Bison operates over 650 channels including PGA Tour and US Open on YouTube, Cooking Wild and DIY & Crafts on Facebook and Slick and VSatisfying on Snap Discover.

The second line of business involves the execution of social and digital advertising campaigns for global, blue-chip brands such as Panasonic, New Balance, Primark, Vodafone and Samsung.

 

The Company operates through three divisions: Brave Bison Social & Influencer, a social advertising practice, Brave Bison Commerce, a digital commerce practice, and Brave Bison Performance, a paid and organic digital media practice.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGGNGNGGZZZ
Date   Source Headline
22nd Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSNotice of Results & Investor Presentation
10th Mar 20234:58 pmRNSHolding(s) in Company
9th Mar 202311:43 amRNSHolding(s) in Company
21st Feb 20231:34 pmRNSHolding(s) in Company
21st Feb 20231:33 pmRNSHolding(s) in Company
21st Feb 20231:32 pmRNSHolding(s) in Company
21st Feb 20231:30 pmRNSHolding(s) in Company
13th Feb 20235:50 pmRNSHolding(s) in Company
13th Feb 202310:23 amRNSHolding(s) in Company
7th Feb 20237:00 amRNSHolding(s) in Company
6th Feb 20235:28 pmRNSHolding(s) in Company
6th Feb 20235:04 pmRNSDirector/PDMR Shareholding
6th Feb 20231:06 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSAcquisition of Social Chain and Vendor Placing
14th Dec 20224:17 pmRNSHolding(s) in Company
7th Dec 202211:17 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSNew Financing Facility
22nd Sep 20227:00 amRNSHalf-year Report
16th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20223:17 pmRNSHolding(s) in Company
22nd Jul 20221:55 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSHalf Year Trading Update
11th Jul 20227:00 amRNSDirectorate Change
29th Jun 20225:04 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
6th Jun 20227:00 amRNSSignificant Contract Wins
27th May 20224:21 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.